⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

May 10, 2024Open Access

Evolution towards extremely high β-lactam resistance inMycobacterium abscessusoutbreak strains

Eva Le Run Hervé Tettelin Steven M. Holland Adrian M. Zelazny

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Treatment of

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Run et al. (2024) studied this question.

synapsesocial.com/papers/68e6ab25b6db64358762d85c https://doi.org/10.1101/2024.05.08.593223

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Evolution toward extremely high imipenem resistance in <i>Mycobacterium abscessus</i> outbreak strains2024 · 8 citations
2Dual β-lactam therapy to improve treatment outcome in Mycobacterium abscessus disease2024 · 17 citations
3Treatment ofMycobacterium abscessusInfectionOriginal Research · 2016 · 108 citations
4Eradicating Pulmonary Mycobacterium abscessus : The Promise of Dual β-Lactam TherapyOriginal Research · 2023 · 21 citations
5The Role of β-Lactam Antibiotics in Treating <i>Mycobacterium abscessus</i>: From Laboratory Insights to Clinical Applications and the Case for Clinical Trials2025 · 5 citations